Mast Cells in Lung Damage of COVID-19 Autopsies: a descriptive study
Allergy. 2022 Mar 27. doi: 10.1111/all.15293. Online ahead of print. NO ABSTRACT PMID:35340030 | DOI:10.1111/all.15293
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Science. 2020 Aug 14;369(6505):806-811. doi: 10.1126/science.abc6284. Epub 2020 May 20. ABSTRACT The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus
SARS-CoV-2-specific ELISA development
J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. ABSTRACT Critical to managing the spread of COVID-19 is the ability to diagnose infection
Reported drug allergies among patients with opioid use disorder: Role for allergy evaluation and intervention
Ann Allergy Asthma Immunol. 2021 Apr;126(4):433-435. doi: 10.1016/j.anai.2020.12.017. Epub 2020 Dec 30. NO ABSTRACT PMID:33387617 | PMC:PMC8210817 | DOI:10.1016/j.anai.2020.12.017
Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation
Sci Immunol. 2021 Feb 26;6(56):eabb7221. doi: 10.1126/sciimmunol.abb7221. ABSTRACT Mast cells (MCs) play a pathobiologic role in type 2 (T2) allergic inflammatory diseases of the airway,
The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation
Sci Immunol. 2018 Oct 5;3(28):eaat9453. doi: 10.1126/sciimmunol.aat9453. ABSTRACT Respiratory epithelial cells (EpCs) orchestrate airway mucosal inflammation in response to diverse environmental stimuli, but how distinct